United Therapeutics Announces New $2 Billion Share Repurchase Program

Key Facts

United Therapeutics announced an additional $2 billion stock buyback plan. Seeking Alpha reported that the company authorized the new repurchase program for its common stock, which remains available through October 21, 2027, adding to its existing capital return initiatives.

UTHR closed at $563.49 on October 21, 2026, following a session that saw a day high of $566.55 and a low of $550.06. This new authorization follows an accelerated share repurchase transaction that the company entered into in September 2026.